Santa Monica, CA, United States of America

Leticia M Toledo-Sherman

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 7 EPO patents, primarily in Pharmaceutical Compositions. Top assignee: Chdi Foundation, Inc.. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leticia M Toledo-Sherman. Retrieved from https://idiyas.com/inventor/leticia-m-toledo-sherman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 94.1


 

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Kynurenine-3-Monooxygenase
Inhibitors
Pharmaceutical Compositions
HIV Treatments
Compositions
Methods of Use
Solid Forms
Kinase Inhibitors
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Leticia M. Toledo-Sherman

Introduction

Leticia M. Toledo-Sherman, a prominent inventor based in Santa Monica, California, has made significant strides in the field of biochemistry and pharmacology. With an impressive portfolio of 17 patents, she focuses on developing innovative therapeutic compounds aimed at improving health outcomes.

Latest Patents

Among her latest patents are the "ATM kinase inhibitors and compositions and methods of use thereof," which detail specific ATM kinase inhibitors of Formula I. This patent encompasses compounds and methods that hold potential for various therapeutic applications. Furthermore, she has developed novel "Solid forms of a kynurenine-3-monooxygenase inhibitor," which involves the preparation and characterization of 6-(3-chloro-4-cyclopropoxyphenyl)pyrimidine-4-carboxylic acid (Compound I) in solid state. This patent outlines the processes for manufacture and methods for utilizing these forms of Compound I, including its salts and co-crystals.

Career Highlights

Leticia currently works at the CHDI Foundation, Inc., an organization dedicated to developing therapies for Huntington's disease. Her extensive research and development efforts at CHDI focus on creating groundbreaking pharmacological solutions that aim to alleviate debilitating symptoms associated with this neurodegenerative disorder.

Collaborations

Throughout her career, Leticia has collaborated with talented colleagues, including Celia Dominguez and Michael Edward Prime. These partnerships have allowed her to blend expertise and enhance the innovation process, leading to the successful creation of valuable therapeutic agents.

Conclusion

Leticia M. Toledo-Sherman's contributions to the field of chemistry and pharmacology are noteworthy and continue to impact the industry positively. Her innovative research and dedication to developing effective therapeutics highlight her as a key figure in contemporary scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…